Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Microbot Medical (MBOT) Change in Receivables (2016)

Microbot Medical's Change in Receivables history spans 7 years, with the latest figure at -$540000.0 for Q4 2016.

  • For the quarter ending Q4 2016, Change in Receivables fell 1230.98% year-over-year to -$540000.0, compared with a TTM value of -$538000.0 through Dec 2016, down 715.15%, and an annual FY2018 reading of $40000.0, up 185.71% over the prior year.
  • Change in Receivables for Q4 2016 was -$540000.0 at Microbot Medical, down from $12000.0 in the prior quarter.
  • The five-year high for Change in Receivables was $92578.0 in Q4 2014, with the low at -$540000.0 in Q4 2016.
  • Average Change in Receivables over 5 years is -$25084.9, with a median of -$7831.0 recorded in 2014.
  • Year-over-year, Change in Receivables surged 6388.98% in 2012 and then plummeted 1493.99% in 2015.
  • Tracing MBOT's Change in Receivables over 5 years: stood at $9867.0 in 2012, then surged by 446.9% to $53963.0 in 2013, then skyrocketed by 71.56% to $92578.0 in 2014, then crashed by 48.43% to $47746.0 in 2015, then tumbled by 1230.98% to -$540000.0 in 2016.
  • Per Business Quant, the three most recent readings for MBOT's Change in Receivables are -$540000.0 (Q4 2016), $12000.0 (Q3 2016), and -$3000.0 (Q2 2016).